BridgeBio Pharma, Inc 10-K for FY2021
BridgeBio Pharma, Inc. (BBIO)
10-K
2022-02-25
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 10-K
BridgeBio Pharma, Inc filed this 10-K on February 25, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $69.72M
- up 745.1% from $8.25M a year earlier
- Net loss
- $586.45M
- compared with a net loss of $505.49M a year earlier